Drug Type Small molecule drug |
Synonyms VU0409106 |
Target |
Mechanism mGluR5 modulators(Metabotropic glutamate receptor 5 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H11FN4O2S |
InChIKeyAXVLPJHYYFHCHK-UHFFFAOYSA-N |
CAS Registry1276617-62-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anxiety Disorders | Preclinical | US | 01 Nov 2013 |